BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36465334)

  • 1. Case report: Treatment of metastatic dedifferentiated chondrosarcoma with pembrolizumab yields sustained complete response.
    Singh A; Thorpe SW; Darrow M; Carr-Ascher JR
    Front Oncol; 2022; 12():991724. PubMed ID: 36465334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Retrospective Multi-Institutional Cohort Analysis of Clinical Characteristics and Outcomes in Dedifferentiated Chondrosarcoma.
    Bui N; Dietz H; Farag S; Hirbe AC; Wagner MJ; Van Tine BA; Ganjoo K; Jones RL; Keedy VL; Davis EJ
    Cancers (Basel); 2023 May; 15(9):. PubMed ID: 37174084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Systematic Review of Adjuvant Chemotherapy in Localized Dedifferentiated Chondrosarcoma.
    Tsukamoto S; Mavrogenis AF; Nitta Y; Righi A; Masunaga T; Honoki K; Fujii H; Kido A; Tanaka Y; Tanaka Y; Errani C
    Curr Oncol; 2024 Jan; 31(1):566-578. PubMed ID: 38275833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dedifferentiated Chondrosarcoma from Molecular Pathology to Current Treatment and Clinical Trials.
    Zając W; Dróżdż J; Kisielewska W; Karwowska W; Dudzisz-Śledź M; Zając AE; Borkowska A; Szumera-Ciećkiewicz A; Szostakowski B; Rutkowski P; Czarnecka AM
    Cancers (Basel); 2023 Aug; 15(15):. PubMed ID: 37568740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of angiogenesis markers HSP70, HSP90, VEGF and pERK1/2 in both components of dedifferentiated chondrosarcomas.
    Schoedel K; Miller V; Osei-Hwedieh D; Watters R; Duensing A; John I; Chandran U; Chang A; Soman V; Weiss K
    J Bone Oncol; 2021 Aug; 29():100370. PubMed ID: 34094840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features and treatment outcomes of dedifferentiated and grade 3 chondrosarcoma: A multi-institutional study.
    Kozawa E; Nishida Y; Kawai A; Hayakawa K; Setsu N; Kawashima H; Iwata S; Tsuchiya H; Tsukushi S; Takenaka S; Imanishi J; Baba I; Nagano A; Morii T; Shirai T; Shimizu K; Kawano H
    Cancer Sci; 2022 Jul; 113(7):2397-2408. PubMed ID: 35485870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of miRNA expression in dedifferentiated and well-differentiated components of dedifferentiated chondrosarcoma.
    Karras FS; Schreier J; Körber-Ferl K; Ullmann SR; Franke S; Roessner A; Jechorek D
    Pathol Res Pract; 2023 Apr; 244():154414. PubMed ID: 36963273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study.
    Hompland I; Ferrari S; Bielack S; Palmerini E; Hall KS; Picci P; Hecker-Nolting S; Donati DM; Blattmann C; Bjerkehagen B; Staals E; Kager L; Gambarotti M; Kühne T; Eriksson M; Ferraresi V; Kevric M; Biagini R; Baumhoer D; Brosjø O; Comandone A; Schwarz R; Bertulli R; Kessler T; Hansson L; Apice G; Heydrich BN; Setola E; Flörcken A; Ruggieri P; Krasniqi F; Hofmann-Wackersreuther G; Casali P; Reichardt P; Smeland S
    Eur J Cancer; 2021 Jul; 151():150-158. PubMed ID: 33990016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dedifferentiated chondrosarcoma of the middle finger arising from a solitary enchondroma: A case report.
    Yonezawa H; Yamamoto N; Hayashi K; Takeuchi A; Miwa S; Igarashi K; Morinaga S; Asano Y; Saito S; Tome Y; Ikeda H; Nojima T; Tsuchiya H
    World J Clin Cases; 2022 Apr; 10(10):3297-3305. PubMed ID: 35647122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dedifferentiated Chondrosarcoma of Proximal Tibia and Fibula with an Infected Ulcer: A Case Report.
    Pattanashetty OB; B B D; Pillai A; Endigeri P
    J Orthop Case Rep; 2016; 6(2):9-12. PubMed ID: 27703929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and characterization of a novel dedifferentiated chondrosarcoma cell line, SMU-DDCS, harboring an IDH1 mutation.
    Emori M; Nakahashi N; Takasawa A; Murata K; Murahashi Y; Shimizu J; Tsukahara T; Sugita S; Takada K; Hasegawa T; Osanai M; Iba K
    Hum Cell; 2023 Nov; 36(6):2195-2203. PubMed ID: 37454032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BMPR2-pSMAD1/5 signaling pathway regulates RUNX2 expression and impacts the progression of dedifferentiated chondrosarcoma.
    Yang K; Tang XD; Guo W; Xu XL; Ren TT; Ren CM; Wang SD; Bao X; Zhang F; Sun KK
    Am J Cancer Res; 2016; 6(6):1302-16. PubMed ID: 27429845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case Report: Durable Complete Response After Combined Immunotherapy Following Resection of Primary Tumor in a Gallbladder Cancer Patient With Distant Metastatic Lymph Nodes of Favorable Immune-Microenvironment.
    Yi B; Zhao Z; Dong H; Yuan L; Wu Y; Xu Y; Jiang X; Sun C; Wu D; Xiao Y
    Front Immunol; 2022; 13():820566. PubMed ID: 35242133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dedifferentiated chondrosarcoma of the ring finger: a case report of an exceptional surgical treatment and review of literature.
    Mani O; Andreani L; D'Arienzo A; Colangeli S; Capanna R
    Orthop Rev (Pavia); 2022; 14(3):33581. PubMed ID: 35775033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of immunotherapy in chondrosarcoma: A case report and review of the literature.
    Cohen-Nowak AJ; Dressler DB; Rock A; Mojica K; Woo D; Zuckerman LM; Chow W; Agulnik M
    Ther Adv Med Oncol; 2023; 15():17588359231199877. PubMed ID: 37745839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TCF-1 participates in the occurrence of dedifferentiated chondrosarcoma.
    Xu X; Tang X; Guo W; Yang K; Ren T
    Tumour Biol; 2016 Oct; 37(10):14129-14140. PubMed ID: 27522523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant benefits of pembrolizumab in treating refractory advanced pulmonary sarcomatoid carcinoma: A case report.
    Chen P; Yu M; Zhang JL; Chen WY; Zhu L; Song Y; Jiang CY; Zhang S
    World J Clin Cases; 2020 Jul; 8(13):2876-2884. PubMed ID: 32742998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonality analysis and
    Yang T; Bai Y; Chen J; Sun K; Luo Y; Huang W; Zhang H
    J Bone Oncol; 2020 Jun; 22():100293. PubMed ID: 32742915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune checkpoint inhibitors in head and neck squamous cell carcinoma: A systematic review of phase-3 clinical trials.
    Poulose JV; Kainickal CT
    World J Clin Oncol; 2022 May; 13(5):388-411. PubMed ID: 35662989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary dedifferentiated chondrosarcoma of the lung with a 4-year history of breast cancer: A case report.
    Wen H; Gong FJ; Xi JM
    World J Clin Cases; 2023 May; 11(13):3022-3028. PubMed ID: 37215415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.